Personal tools

Coexpression cluster:C3609

From FANTOM5_SSTAR

Revision as of 21:29, 22 January 2013 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C3609_osteosarcoma_embryonic_Reticulocytes_testicular_chronic_Hep2_teratocarcinoma



Phase1 CAGE Peaks

Hg19::chr17:17184546..17184569,-p1@COPS3
Hg19::chr17:17184575..17184592,-p2@COPS3
Hg19::chr17:17184605..17184622,-p3@COPS3


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br>disease_data<br>


Uber Anatomy
Ontology termp-valuen
upper respiratory tract7.59e-0819
larynx2.16e-079
Disease
Ontology termp-valuen
disease of cellular proliferation5.84e-18239
cancer1.05e-16235
cell type cancer1.09e-11143
carcinoma9.24e-08106


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)
MA0003.10.708947
MA0004.10.826076
MA0006.10.639288
MA0007.10.804807
MA0009.11.3275
MA0014.11.24048
MA0017.10.686276
MA0019.10.990656
MA0024.12.72668
MA0025.11.46617
MA0027.12.95767
MA0028.11.58389
MA0029.11.23771
MA0030.11.22561
MA0031.11.15713
MA0038.10.94098
MA0040.11.24388
MA0041.10.847069
MA0042.10.810843
MA0043.11.32783
MA0046.11.31611
MA0048.10.341392
MA0050.10.81185
MA0051.10.936307
MA0052.11.24796
MA0055.10.190716
MA0056.10
MA0057.10.333427
MA0058.10.716037
MA0059.10.714521
MA0060.10.492218
MA0061.10.456531
MA0063.10
MA0066.10.941452
MA0067.11.65513
MA0068.10.405474
MA0069.11.31207
MA0070.11.30033
MA0071.10.897953
MA0072.11.29561
MA0073.10.0185922
MA0074.10.935474
MA0076.12.91768
MA0077.11.28751
MA0078.11.04495
MA0081.11.70054
MA0083.11.33535
MA0084.11.84562
MA0087.11.29304
MA0088.10.715722
MA0089.10
MA0090.10.751469
MA0091.10.829044
MA0092.10.785956
MA0093.10.642957
MA0095.10
MA0098.10
MA0100.10.956299
MA0101.10.646932
MA0103.10.628063
MA0105.10.31555
MA0106.10.986396
MA0107.10.556367
MA0108.21.15387
MA0109.10
MA0111.10.767139
MA0113.11.00436
MA0114.10.549955
MA0115.11.57693
MA0116.10.560723
MA0117.11.36676
MA0119.10.695578
MA0122.11.39371
MA0124.11.53432
MA0125.11.44766
MA0130.10
MA0131.11.06461
MA0132.10
MA0133.10
MA0135.11.35921
MA0136.10.948776
MA0139.10.440097
MA0140.10.894983
MA0141.10.712476
MA0142.11.12317
MA0143.11.00455
MA0144.10.531867
MA0145.10.273764
MA0146.10.107247
MA0147.10.565108
MA0148.10.854239
MA0149.10.884158
MA0062.22.96208
MA0035.20.894194
MA0039.20.0526989
MA0138.21.04628
MA0002.21.20011
MA0137.20.666381
MA0104.20.491226
MA0047.20.973066
MA0112.20.264678
MA0065.20.277623
MA0150.10.744617
MA0151.10
MA0152.12.08673
MA0153.11.43021
MA0154.10.312019
MA0155.10.256269
MA0156.11.60572
MA0157.11.09377
MA0158.10
MA0159.10.565904
MA0160.10.871361
MA0161.10
MA0162.10.149099
MA0163.10.387745
MA0164.11.01792
MA0080.20.643061
MA0018.22.26143
MA0099.20.902716
MA0079.20.0373086
MA0102.21.88331
MA0258.10.519674
MA0259.11.40979
MA0442.10



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
BRCA1#672320.18423064322380.0001215704860271640.00164124870607432
CCNT2#90536.336201576962630.003930750035764890.0189802396312936
CEBPB#105137.971147625824820.001974187055288560.0115121229406634
CHD2#1106310.34402283411690.0009033701102746880.00659815867871726
E2F1#186934.907389214879320.008460985347239390.0324802193883825
E2F4#1874312.66806031528440.0004917987006298980.00436611394891924
E2F6#187635.017155731697390.00791769806886330.0321619722536663
EGR1#195834.988179094810140.008056488137383440.0320147463884099
ELF1#199734.258097958807540.01295179875054610.0461584340456674
ELK4#2005316.2356816584680.0002336043955745990.00255550533878868
ETS1#211339.728760922202340.001085840092584840.00761356518492566
GABPB1#255337.067683836182170.002832212825417420.015392281587853
MAX#414936.452555509007120.003721913834265510.0186307974950563
MYC#460935.22228187160940.007020843755740150.0294123506219714
PAX5#507936.669565531177830.003370290999677260.017273878476483
POU2F2#545239.106124057742520.001324165192682130.00881305687984508
RFX5#5993312.04791082719510.0005717246050312580.00484111772538183
SIN3A#2594235.408884726815140.006318961977991520.027626677412067
SP1#666735.69838137814090.005403962701712170.0246144385103632
TAF7#6879311.43306940492390.0006690181981945830.0054210250291911
TFAP2A#7020316.5186343730450.0002218033880766340.00247938821013974
TFAP2C#7022310.80922860986020.0007916746575753130.00614825323932987
TRIM28#10155318.59052504526250.0001555969297255280.00196878940436205
USF1#739136.361499277207960.00388404057290560.0190042311264319
YY1#752834.911170749853860.008441455341808260.0328863456596207
ZBTB33#10009331.66472502998123.14815888737575e-050.00063362992106116
ZNF263#1012738.221841637010680.001799043925565870.0109283050393866



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.